Finance

Lists
Why is DSGN down 6,35%?
Dive Deeper
DSGN:NASDAQ
Design Therapeutics Inc
10,91 USD
-6,35%
(-0,74) 1D
11,01 USD
+0,92% (+0,10)
Pre-market
Closed: 12-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSGN...
Open
11,67 USD
High
11,82 USD
Low
10,89 USD
Mkt. cap
682,77 млн
Avg. vol.
707,23 миң
Volume
666,00
52-wk high
17,25 USD
52-wk low
5,28 USD
EPS
-1,18 USD
Beta
1,68
Shares outstanding
62,58 млн
No. of employees
55
Open
11,67 USD
High
11,82 USD
Low
10,89 USD
Mkt. cap
682,77 млн
Avg. vol.
707,23 миң
Volume
666,00
52-wk high
17,25 USD
52-wk low
5,28 USD
EPS
-1,18 USD
Beta
1,68
Shares outstanding
62,58 млн
No. of employees
55
News stories
From web sources and news partners
About Design Therapeutics Inc
CEO-
Employees55
Founded2017
HeadquartersКарлсбад, Калифорния, Америка Кошмо Штаттары
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to DSGN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for DSGN in the last 3 months.
Highest
Current 10,91 USD
40,54 USD (+271,59%)
Average
27,14 USD (+148,76%)
Lowest
20,00 USD (+83,32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tianqi Hang
Wells Fargo
Buy
Initiated
26,00 USD
+138,3%
10/12/2026
Unknown Analyst
Wells Fargo
Buy
Initiated
26,00 USD
+138,3%
10/02/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Maintained
40,54 USD
+271,6%
08/05/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
22,00 USD
+101,6%
08/04/2026
Leonid Timashev
RBC Capital
Buy
Maintained
20,00 USD
+83,3%
08/03/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
21,00 USD
+92,5%
06/15/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
20,00 USD
+83,3%
05/27/2026
Faisal Khurshid
Jefferies
Buy
Initiated
15,00 USD
+37,5%
03/15/2026
Luca Issi
RBC Capital
Buy
Reiterated
14,00 USD
+28,3%
03/09/2026
Last report
2026-ж., 3-авг.
Fiscal period
Q2 2026
-0,32 USD / -0,34 USD
+7,06%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
14,59 млн
13,42 млн
14,38 млн
16,39 млн
Cost of revenue
14,59 млн
13,42 млн
14,38 млн
16,39 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,72 млн
4,74 млн
5,33 млн
5,79 млн
Operating expense
4,72 млн
4,74 млн
5,33 млн
5,79 млн
Total operating expenses
19,31 млн
18,17 млн
19,71 млн
22,18 млн
Operating income
-19,31 млн
-18,17 млн
-19,71 млн
-22,18 млн
Other non operating income
-
-
-
-
EBT including unusual items
-17,00 млн
-16,00 млн
-17,64 млн
-20,16 млн
EBT excluding unusual items
-17,00 млн
-16,00 млн
-17,64 млн
-20,16 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17,00 млн
-16,00 млн
-17,64 млн
-20,16 млн
Net profit margin
-
-
-
-
Earnings per share
-0,30
-0,27
-0,29
-0,32
Interest and investment income
2,31 млн
2,17 млн
2,07 млн
2,01 млн
Interest expense
-
-
-
-
Net interest expenses
2,31 млн
2,17 млн
2,07 млн
2,01 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,16 млн
-18,01 млн
-19,55 млн
-22,03 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору